Jennifer M. Shotwell is a Founding Managing Director of Innisfree. Ms. Shotwell has more than twenty-five years of experience in designing strategies to win shareholder support and in overseeing the analysis, communications and implementation required in hostile transactions and extraordinary solicitations. Ms. Shotwell also counsels clients on a wide range of other matters, including special and annual meeting solicitations, tender and exchange offer dynamics and corporate governance issues.
Recent activist/takeover situations she has worked on include: the successful defense at Chico’s FAS against a proxy contest by the Barington Group, the successful defense at Norfolk Southern against an unsolicited takeover bid by Canadian Pacific, the successful defense at DuPont against a proxy contest by Trian Partners; the successful defense at Allergan against the unsolicited offer by Valeant Pharmaceuticals and Pershing Square Capital Management; the successful defense at Aspen Insurance against the unsolicited tender offer and accompanying solicitation of calls for special meetings by Endurance Specialty Holdings; the defense at Transocean against the proxy contest conducted by Carl Icahn; the successful defense at Agrium against JANA Partners’ proxy contest; and the successful defense at Oshkosh Corporation against a proxy contest and unsolicited tender offer by Carl Icahn.
Other iconic proxy contests in which Ms. Shotwell has been involved include Airgas’s successful defense against the unsolicited bid by Air Products, Weyerhaeuser’s successful unsolicited bid to acquire Willamette Industries, and the HP/Walter Hewlett proxy contest to approve the HP/Compaq merger.
Ms. Shotwell serves on the Board of Advisors at the University of Pennsylvania’s Institute for Law and Economics and is a member of the National Investor Relations Institute, the Society for Corporate Governance and the Securities Industry and Financial Markets Association. Ms. Shotwell earned a B.A. in Philosophy from Swarthmore College.